Former Mossad chief Tamir Pardo has joined NRx Pharmaceuticals, the company completing clinical trials for the Israeli COVID-19 vaccine, as a member of the board of directors, the firm announced this week.
The addition of Pardo, who served as head of the Mossad between 2011 and 2016, is meant to help the company push forward with the commercialization of the jab, it indicated.
[ + ] observation1
[ - ] observation1 1 point 3.7 yearsSep 2, 2021 04:28:47 ago (+1/-0)